A comparison of viral loads between HIV-1-infected elite suppressors and individuals who receive suppressive highly active antiretroviral therapy.
about
New tools for quantifying HIV-1 reservoirs: plasma RNA single copy assays and beyondRecent advances on the use of structural biology for the design of novel envelope immunogens of HIV-1Elite suppressors harbor low levels of integrated HIV DNA and high levels of 2-LTR circular HIV DNA compared to HIV+ patients on and off HAART.A flavonoid, luteolin, cripples HIV-1 by abrogation of tat function.In vivo HIV-1 hypermutation and viral loads among antiretroviral-naive Brazilian patients.HIV RNA levels in plasma and cervical-vaginal lavage fluid in elite controllers and HAART recipients.Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers.HIV-1 continues to replicate and evolve in patients with natural control of HIV infectionEffector mechanisms in HIV-1 infected elite controllers: highly active immune responses?T cell Activation does not drive CD4 decline in longitudinally followed HIV-infected Elite ControllersElevated caspase-3 expression and T-cell activation in elite suppressors.Improved estimation of the distribution of suppressed plasma HIV-1 RNA in men receiving effective antiretroviral therapyComprehensive analysis of unique cases with extraordinary control over HIV replication.Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy.Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control.Effect of antiretroviral therapy on HIV reservoirs in elite controllers.T cell dynamics and the response to HAART in a cohort of HIV-1-infected elite suppressorsHLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice.Single-copy assay quantification of HIV-1 RNA in paired cerebrospinal fluid and plasma samples from elite controllersMucosal immunity in HIV controllers: the right place at the right time.The implications of viral reservoirs on the elite control of HIV-1 infection.Cell-Mediated Immunity in Elite Controllers Naturally Controlling HIV Viral Load.HIV controllers: a genetically determined or inducible phenotype?Viral suppression of multiple escape mutants by de novo CD8(+) T cell responses in a human immunodeficiency virus-1 infected elite suppressor.Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers.Prolonged control of replication-competent dual- tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy.Demographics and natural history of HIV-1-infected spontaneous controllers of viremia.Maintenance of HIV-Specific Memory B-Cell Responses in Elite Controllers Despite Low Viral BurdensEvolution of the HIV-1 nef gene in HLA-B*57 positive elite suppressorsPrimary CD8+ T cells from elite suppressors effectively eliminate non-productively HIV-1 infected resting and activated CD4+ T cells.Evidence of CD8+ T-cell-mediated selective pressure on human immunodeficiency virus type 1 nef in HLA-B*57+ elite suppressors.Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus.Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters.
P2860
Q27027164-C246106B-FEF5-4CB1-9D26-D6C97C358DEAQ30353580-59A48B2B-991F-48D5-BAFD-40918C13D70CQ33839450-727AFD5B-AD23-4F12-8566-DCB2131E4587Q34091121-F39573AD-4BDE-4FEE-98A7-6F4E41FD3B59Q34116867-77CDB81B-69B0-440F-AAA2-1710D06C7B7DQ34159418-88287872-94E4-4B90-AF7C-D82C283D5985Q34189960-5B06C2A9-D81C-4F9C-9656-8B9E22654222Q34416428-7BDD0B07-B8D1-4BC5-8D1E-FE2C6DFCF56FQ35001377-F8D35001-7E1F-4151-92BB-75D74075652FQ35090639-5268F0A3-A7F6-473B-AB85-6C51AB34A9F3Q35586299-8E2C90BC-E5EF-444F-97F6-7E8C35D30D6EQ35823114-51AE6E38-87D5-42DF-B9A2-738F05D33067Q36010191-1B5A2DE8-8EC0-4D95-B202-65527C105E9EQ37033224-D3928029-5C5D-49D0-8860-35A17D6C1F3DQ37054526-2CEFF89A-2818-4EA8-B4C4-117F3F861A7DQ37212990-1B62D3DE-41A9-4F4D-A15E-01C83A7E5940Q37439446-BE52F319-DF66-4E54-A789-D6B104BF4273Q37643772-FF88FE15-3488-49FC-B204-A3956E055D90Q37732233-99F953B7-D736-4DD8-8B5E-531E4112DE5BQ37852547-152F387A-E182-41B1-8A9C-81976CD11AF7Q38032153-F61105F9-C497-46EC-813D-498947F8E4D0Q38098176-709183A6-5872-4D19-BB3C-2BCDBC931E34Q38114915-2215DE0E-2820-4972-BCFC-E8270110E78EQ38425723-EFBFBA64-E9C1-4038-88F7-F996224CB4D1Q39112993-83517C8B-D465-4756-85EF-5FD07152771AQ39425108-F5F77068-6D7F-4915-ABA8-AF046C3D20DAQ40291456-4241C7C7-3020-442E-B645-EF7E5F5CEDC3Q40695938-64B922A8-D3DC-4161-B22B-8FEF4CEDD89BQ41444622-6686E7BB-0C9B-47F3-A3F7-5627A3D10399Q41915015-F210A8D4-DCC6-41C7-AB84-5EB0D6E3B770Q42155467-2A227F25-AD43-4DE9-8EE6-970B80B69274Q42737606-6DB5C908-24EA-4285-B6F0-73A4A090228AQ43070781-B49E3623-2677-4761-88B0-5D3D56284E04
P2860
A comparison of viral loads between HIV-1-infected elite suppressors and individuals who receive suppressive highly active antiretroviral therapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
A comparison of viral loads be ...... active antiretroviral therapy.
@en
type
label
A comparison of viral loads be ...... active antiretroviral therapy.
@en
prefLabel
A comparison of viral loads be ...... active antiretroviral therapy.
@en
P2093
P2860
P356
P1476
A comparison of viral loads be ...... active antiretroviral therapy.
@en
P2093
Jason B Dinoso
Joel N Blankson
Scott Y Kim
P2860
P304
P356
10.1086/588791
P407
P577
2008-07-01T00:00:00Z